Quarterly report pursuant to Section 13 or 15(d)

Certain Balance Sheet Items

v3.7.0.1
Certain Balance Sheet Items
6 Months Ended
Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Certain Balance Sheet Items

3. Certain Balance Sheet Items

The following table shows certain balance sheet items (in thousands).

 

     June 30,      December 31,  
     2017      2016  
     (unaudited)         

Accrued compensation

   $ 1,628      $ 1,839  

Accrued pre-clinical and clinical trial expenses

     1,360        1,623  

Accrued professional fees

     364        982  

Deferred revenue

     207        —    

Other accruals

     33        57  
  

 

 

    

 

 

 

Total accrued liabilities

   $ 3,592      $ 4,501